XYL Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Xylem Inc. (XYL)
NEW YORK CITY, NY / ACCESS Newswire / October 29, 2026 / Ten weeks after a Form 8-K filed with the SEC stated it was "reaffirming" its full-year 2026 guidance, Xylem Inc. (NYSE:XYL) cut its adjusted EPS outlook on October 27, 2026 to $5.40-$5.45 from $5.55-$5.70, and shares fell. Investors who lost money on Xylem shares are encouraged to submit their loss information today. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.
The guidance history appears in the Company's own filings and calls. On July 28, 2026, then-CFO William Grogan raised the full-year range, telling investors that first-half results "gives us confidence to raise the EPS range from $5.35 to $5.60 to $5.55 to $5.70." On August 18, 2026, Xylem announced the appointment of its new CFO, Andrea van der Berg, while simultaneously "reaffirming its third-quarter and full-year 2026 guidance issued on July 28, 2026."
On October 27, 2026, Xylem announced it was slashing its revenue outlook from "roughly 9.2 billion" to "approximately $8.95 billion." The company further disclosed a reduced earnings range of $5.40-$5.45 per share, which sits $0.20 per share below the midpoint of the guidance reaffirmed in August, a cut of roughly 3.6%. Levi & Korsinsky is investigating potential securities law violations related to these disclosures.
Shareholders who suffered losses on XYL are encouraged to request a free review of their Xylem losses or call (212) 363-7500.
WHY LEVI & KORSINSKY -- Ranked in ISS Securities Class Action Services' Top 50 Report for seven consecutive years, Levi & Korsinsky, LLP is a nationally recognized leader in shareholder rights litigation. With a team of over 70 professionals, the firm has recovered hundreds of millions of dollars for investors.
Frequently Asked Questions About the XYL Investigation
Q: Who is eligible to participate in the XYL investigation? A: Investors who purchased XYL stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.
Q: Which statements are being investigated as potentially misleading? A: The investigation concerns whether Xylem Inc. made materially false or misleading statements regarding its full-year 2026 guidance, including the subsequent reaffirmation of its guidance alongside the appointment of its new Chief Financial Officer on August 18, 2026.
Q: What do XYL investors need to do right now? A: Investors may gather brokerage records showing purchase dates, share quantities, and prices paid. Submit your information for a no-cost, no-obligation evaluation of your potential recovery. No immediate action is required to remain eligible to participate in the investigation.
Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.
Q: What if I already sold my XYL shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought XYL and sold at a loss may still participate in the investigation.
Q: What does it cost me to participate? A: There is no upfront cost to submit your information and review whether you may be eligible to recover. Should you choose to participate in any resulting action, these matters are generally handled on a contingency basis, with any attorneys' fees and expenses subject to court approval.
Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions. If legal action is later pursued, the overwhelming majority of affected investors never appear in court either.
Attorney Advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
SOURCE: Levi & Korsinsky, LLP